An Imidazo[2,1‐b][1,3,4]thiadiazole Derivative Inhibits the Virulence Factor α‐Hemolysin by Blocking the Pullout of Its Stem Domain
ChemMedChem · 25.02.2026 · 21 (4)
DOI: 10.1002/cmdc.202501098 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 23.02.2026. Verfasst von Vadim S Korotkov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany. Hauptthemen laut MEDLINE: Thiadiazoles, Hemolysin Proteins, Bacterial Toxins, Anti-Bacterial Agents. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helmholtz validation fund, EU-OPENSCREEN Impulse initiative, European Cooperation in Science and Technology.
Abstract (Originalsprache)
Staphylococcus aureus is a major human pathogen responsible for severe infections that necessitate alternative therapeutic strategies. Its key virulence factor α‐hemolysin (Hla) mediates host cell damage via pore formation, making it an attractive target for antivirulence interventions. Here, we report the development of a high‐throughput cellular assay measuring toxin‐induced calcium influx. Its application led to the identification of thiadiazole‐based small molecule inhibitors of Hla. Structure–activity relationship studies with 18 analogs led to inhibitors with a cellular potency up to 5.4 µM. X‐ray crystallography of Hla in complex with compound 1 revealed that the thiadiazole bound a hydrophobic pocket at the interface of the amino latch and prestem domains, exerting a dual mechanism that blocks stem loop unfolding as well as membrane attachment. These findings introduce thiadiazoles as a novel chemical class of antivirulence therapeutics against S. aureus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
- Structure and Function of Proteins, Helmholtz Centre for Infection Research, Braunschweig, Germany.
- Lead Discovery Center, Dortmund, Germany.
- Compound Profiling and Screening, Helmholtz Centre for Infection Research, Braunschweig, Germany.
- German Center for Infection Research (DZIF), Site Hannover-Braunschweig, Germany.
- Center of Biomolecular Drug Research (BMWZ), Leibniz Universität, Hannover, Germany.
ORCID-Profile: Wulf Blankenfeldt, Mark Brönstrup
Förderung
- Helmholtz validation fund
- EU-OPENSCREEN Impulse initiative
- European Cooperation in Science and Technology
Zitieren
APA
Korotkov, V. S., Lukat, P., Di Lucrezia, R., Shekhar, A., Degenhart, C., Diestel, R., Bilitewski, U., Dinkel, K., Blankenfeldt, W., & Brönstrup, M. (2026). An Imidazo[2,1‐b][1,3,4]thiadiazole Derivative Inhibits the Virulence Factor α‐Hemolysin by Blocking the Pullout of Its Stem Domain. ChemMedChem, 21(4). https://doi.org/10.1002/cmdc.202501098
Vancouver
Korotkov VS, Lukat P, Di Lucrezia R, Shekhar A, Degenhart C, Diestel R, et al. An Imidazo[2,1‐b][1,3,4]thiadiazole Derivative Inhibits the Virulence Factor α‐Hemolysin by Blocking the Pullout of Its Stem Domain. ChemMedChem. 2026;21(4). doi:10.1002/cmdc.202501098
BibTeX
@article{Korotkov2026,
author = {Korotkov, Vadim S and Lukat, Peer and Di Lucrezia, Raffaella and Shekhar, Aditya and Degenhart, Carsten and Diestel, Randi and Bilitewski, Ursula and Dinkel, Klaus and Blankenfeldt, Wulf and Brönstrup, Mark},
title = {An Imidazo[2,1‐b][1,3,4]thiadiazole Derivative Inhibits the Virulence Factor α‐Hemolysin by Blocking the Pullout of Its Stem Domain},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {4},
doi = {10.1002/cmdc.202501098}
}
EUVIMED